The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry

Giancarlo la Marca1, Elisa Giocaliere, Sabrina Malvagia

  • 1Newborn Screening, Biochemistry and Pharmacology Laboratories, Clinic of Pediatric Neurology, Meyer University Children's Hospital, Florence, Italy; Department of Neurosciences, Psychology, Pharmacology and Child Health, University of Florence, Italy.

Insights

Newborn screening for adenosine deaminase-deficient severe combined immunodeficiency (ADA-SCID) is crucial for early intervention. A new, simple, and cost-effective tandem mass spectrometry method enables reliable diagnosis in infants.

Area of Science:

  • Biochemistry
  • Genetics
  • Immunology

Background:

  • Severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) is a life-threatening genetic disorder.
  • Early diagnosis and treatment are critical to prevent severe infections and irreversible damage.
  • Current diagnostic methods may not be suitable for widespread newborn screening.

Purpose of the Study:

  • To develop and validate a robust, cost-effective tandem mass spectrometry method for diagnosing ADA-SCID in newborns.
  • To integrate adenosine and 2-deoxyadenosine testing into an expanded newborn screening program.
  • To establish reference values and a confirmatory second-tier test for improved diagnostic accuracy.

Main Methods:

  • A revised tandem mass spectrometry protocol was developed for analyzing adenosine and 2-deoxyadenosine in dried blood spots.
  • The method was validated using samples from 9 genetically confirmed ADA-SCID patients (4 early-onset, 5 delayed-onset).
  • Reference ranges were established from 50,000 healthy newborns, and a second-tier test was created for confirmation.

Main Results:

  • The developed method demonstrated simplicity, low cost, and minimal preparation, making it suitable for mass screening.
  • Reference values for deoxyadenosine (<0.09 μmol/L) and adenosine (<1.61 μmol/L) were established.
  • A pilot project successfully identified one newborn with a confirmed ADA gene defect within 18 months.

Conclusions:

  • The new tandem mass spectrometry method is effective for the early detection of ADA-SCID in newborn screening programs.
  • Early diagnosis through this screening method allows for timely intervention, improving patient outcomes.
  • The method's applicability to mass screening ensures broader access to diagnosis and treatment for ADA-SCID.

Related Concept Videos

Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Tandem Mass Spectrometry01:21

Tandem Mass Spectrometry

Tandem mass spectrometry is a technique that uses multiple mass analyzers in series to obtain a higher selectivity and reduce chemical noise during analyte detection. Instruments with multiple analyzers separated by an interaction cell enable secondary fragmentation and selected study of the fragment ions.Secondary fragmentations occur in the interaction cell and can be induced by various factors. Fragmentation induced by collision with inert gases, such as N2, Ar, He, etc., is called...
MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...